NIPT is a prenatal screening test that can be performed as early as 10 weeks of pregnancy using a single blood draw. Prenatal diagnostic tests such as amniocentesis and chorionic villus sampling (CVS) diagnose the presence of chromosomal conditions. They are typically performed later in pregnancy and can be associated with a small risk of pregnancy loss.
NIPT or NIPS (non-invasive prenatal screening) looks at fragments of DNA (cell-free DNA or cfDNA) in your blood during pregnancy to provide accurate information about the likelihood of chromosomal conditions that can impact your baby’s health. NIPT (also known as cell-free DNA screening), can be performed as early as 10 weeks of pregnancy and screens for the most common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), 22q11.2 microdeletion and sex chromosome aneuploidies (SCA). An aneuploidy is another word for an extra package of genetic instructions, or an extra missing chromosome. Some NIPTs, such as the Harmony prenatal test, also provide the option of reporting the sex of your baby.
Who should consider NIPT?
Previously, NIPT was offered only to women with pregnancies at high risk for chromosomal conditions, such as women over 35 or with a family history of chromosomal conditions. However, professional societies such as The American College of Medical Genetics and Genomics (ACMG) now recommend that doctors inform all pregnant women regardless of age or risk about the fact that cfDNA-based NIPT is the most sensitive screening option for trisomy 21, trisomy 18 and trisomy 13.1 The International Society for Prenatal Diagnosis (ISPD) considers NIPT as appropriate to be offered to all pregnant women as a primary screening test.2
How safe is NIPT?
NIPT is performed with a simple blood draw from the mother, so it is considered very safe.
How accurate is NIPT?
cfDNA-based NIPT is recognized as the most sensitive screening option for trisomy 21, trisomy 18, and trisomy 13.1 The Harmony prenatal test has been shown to have superior accuracy in a direct comparison to traditional first trimester screening in over 15,000 women.3 However, not all NIPTs perform with the same accuracy. NIPT for very rare conditions, such as those offered in microdeletion panels, have unclear accuracy.
What are the differences between NIPT and diagnostic tests?
NIPT is a blood test that provides you an opportunity to obtain accurate information about the likelihood for the most common chromosomal conditions. It can be performed as early as 10 weeks of pregnancy without posing a risk to the baby. Because NIPT is a prenatal screening test it cannot rule out the possibility of chromosomal conditions. In the case of a high probability result, your care provider may offer follow up testing to confirm a diagnosis.
Prenatal diagnostic tests such as amniocentesis or chorionic villus sampling (CVS) require collection of the baby’s cells in the amniotic fluid or the placenta with a needle and are therefore considered invasive. Diagnostic tests provide a definitive answer; however, they pose a slight chance of pregnancy loss due to the procedure itself.4
Learn more about available prenatal screening and diagnostic test options
Talk to your healthcare provider about your prenatal testing options. Some NIPTs, such as the Harmony test, are available to women of any age, in singleton, twin and egg donor pregnancies. Your doctor will be able to order the test for you.
Download questions you can ask your healthcare provider about the Harmony NIPT.
